Cargando…
Azelaic acid and guanosine in tears improve discrimination of proliferative from non-proliferative diabetic retinopathy in type-2 diabetes patients: A tear metabolomics study
BACKGROUND: Diabetic retinopathy (DR) is the microvascular ocular complication of diabetes mellitus (DM), which can lead to irreversible blindness and visual impairment if not properly treated. Tears can be collected non-invasively, and the compositions of tears could be the potential biomarkers for...
Autores principales: | Wen, Xin, Ng, Tsz Kin, Liu, Qingping, Wu, Zhenggen, Zhang, Guihua, Zhang, Mingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256905/ https://www.ncbi.nlm.nih.gov/pubmed/37305454 http://dx.doi.org/10.1016/j.heliyon.2023.e16109 |
Ejemplares similares
-
Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019) -
Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022) -
Association of UCP1 and UCP2 variants with diabetic retinopathy susceptibility in type-2 diabetes mellitus patients: a meta-analysis
por: Liu, Xujia, et al.
Publicado: (2021) -
Alterations of the Gut Microbiome and Metabolome in Patients With Proliferative Diabetic Retinopathy
por: Ye, Panpan, et al.
Publicado: (2021) -
Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)